To Top

Community

Guy Tiene

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.

Contribution
Announcement

French Pharma Company Ipsen Moves US Headquarters from New Jersey to Boston

PAO-M06-18-NI-013
Investment

Pfizer Expands Investment in Biotech through Pfizer Ventures

PAO-M06-18-NI-010
Oncology

Loxo Oncology Reports Positive Results for Second Targeted Cancer Therapy

PAO-M06-18-NI-001
Clinical Data

More Positive Phase 3 Results for Roche’s Tecentriq

PAO-M05-18-NI-024
Investment

Investing in Chinese Pharma Companies Proves Profitable

PR-M05-18-NI-023
Drug Discovery

TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date

PAO-M05-18-NI-020
Drug Discovery

RNA-Modifying Proteins May Provide New Drug Targets

PAO-M05-18-NI-018
Treatment

New Single-Pill HIV Treatment Approved in Europe

PAO-M05-18-NI-015
Immunotherapy

Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended

PAO-M05-18-NI-010
FDA

New WuXi STA Solid-Dose API Plant Gets Okay from US FDA

PAO-M05-18-NI-004
FDA

New Lung Cancer Treatment Awarded Priority Review by FDA

PAO-M04-18-NI-013
Acquisition

GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis

PAO-M04-18-NI-008
Diabetes

Sanofi’s Sotagliflozin Accepted for Review by EMA

PAO-M04-18-NI-006
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

PAO-M04-18-NI-003
Vaccine

Shingrix Vaccine Available at CVS

PAO-M03-18-NI-018
Drug Development

Bavarian Nordic Expands Partnership with US DOD

PAO-M03-18-NI-017
Strategic Collaboration

WuXi Biologics to Supply Antibody Drugs for Adagene, Inc.

PAO-M03-18-NI-014
Manufacturing

Colorcon Up and Running in Puerto Rico

PAO-M03-18-NI-011
Business

DSM Sinochem Pharmaceuticals Is for Sale

PAO-M03-18-NI-009
Serialization

PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements

PAO-M03-18-NI-008
Roundtable

Q: What Role has M&A Played in your Company’s Growth?

PAP-Q4-17-RT-001
Roundtable

Q: How do you Address Operational Excellence as an Institution?

PAP-Q4-17-RT-002
Drug Development

Celgene, Vividion Therapeutics Collaborate on Novel Protein Drugs

PAO-M03-18-NI-005
Acquistion

Bruker Gains Access to QCL Technology with IRM2 Acquisition

PAO-M03-18-NI-004
DCAT

WuXi AppTec Laboratory Testing Division Becomes DCAT Member

PAO-M03-18-NI-002
Facility

First Order Reported for New Samsung Plant

PAO-M03-18-NI-001
Servier

Servier Reports Year-On-Year Growth

PAO-M02-18-NI-024
Clinical Trials

Aimmune’s AR101 Meets Phase 3 Endpoints

PAO-M02-18-NI-020
Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016
Generics

The Path Toward Generics: 2017’s Record-Breaking Year

PAO-M02-18-NI-015
Acquistion

Allergen Acquires Elastagen

PAO-M02-18-NI-012
Biomanufacturing

Amgen to Open Biomanufacturing Plant in the US

PAO-M02-18-NI-010
Investment

Polpharma Group Gets Digital

PAO-M02-18-NI-008
Drug Development

Mylan and Theravance Will Receive FDA Decision on COPD Drug by November

PAO-M02-18-NI-006
Healthcare

Leading Companies Taking Action to Address Healthcare

PAO-M02-18-NI-005
Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

PAO-M02-18-NI-002
Acquistion

Sanofi Will Acquire Ablynx for €3.9 Billion

PAO-M01-18-NI-045
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Acqusition

Celgene Confirms $9 Billion Buyout of Juno Therapeutics

PAO-M01-18-NI-039
Acquisition

Sanofi Buys Bioverativ

PAO-M01-18-NI-036
Merger

CMC Biologics Becomes AGC Biologics

PAO-M01-18-NI-032
Bioprinting

Sebaceous Glands in 3D

PAO-M01-18-NI-029
Acquistion

Takeda Moves into Stem-Cell Therapies with Acquisition of TiGenix

PAO-M01-18-NI-026
Product Pipeline

Moderna Announces 19 Development Candidates at JPM

PAO-M01-18-NI-021
FDA

FDA Still Addressing Drug Shortages Resulting from Manufacturing Disruptions in Puerto Rico

PAO-M01-18-NI-018
Expansion

Recipharm Expands Stake in India

PAO-M01-18-NI-016
Immunotherapy

Deal with Inovio Launches ApolloBio’s Commercialization Plans in China

PAO-M01-18-NI-009
Biologics

Collaboration Announced Between Takeda Pharmaceutical and Portal Instruments

PAO-M11-17-NI-035
Innovation

London’s Science Museum Displays Breakthrough Stem Cell Sprayer

PAO-M11-17-NI-015
Clinical Data

Bariatric Surgery Demonstrates Effective Diabetes Control

PAO-M11-17-NI-011
Immuno-oncology

Immuno-oncology Approach Based on Electronic Circuitry

PAO-M11-17-NI-008
Topical

New NSAID Topical Gels Penetrate Three Times Faster

PAO-M11-17-NI-004
Research

Studies Show Delayed Umbilical Cord Clamping Might be Key to Life Extension

PAO-M10-17-NI-048
Biologics

ADCs: The Future of Biologic Drugs

PAP-Q04-17-VP-001
Roundtable

Q: Looking forward, what technologies do you anticipate having the greatest impact in 2018?

PAP-Q4-17-RT-002
Capacity Expansion

Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine

PAO-M10-17-NI-043
FDA Approval

First Treatment for Generalized Myasthenia Gravis Approved After 60 Years

PAO-M10-17-NI-039
Information Technology

Fighting Opioid Abuse, Axial Healthcare Rolls Out New IT-based Care Platform

PAO-M10-17-NI-034
Supply Chain

IEEE Releases First Detailed Study of Blockchain Technology in Pharma

PAO-M10-17-NI-027
FDA Approval

FDA Expands 510(k) Clearance for NuVasive’s Limb Lengthening Platform to Include Bone Transport

PAO-M10-17-NI-022
Partnership

Amgen and CytomX Therapeutics Collaborate on the Development of Bispecific Antibodies

PAO-M10-17-NI-018
Innovation

Trial for Cancer Treatment Using Microscopic Beads Begins

PAO-M10-17-NI-014
Innovation

GSK’s Flonase Goes to Market with Smart Shelf Solution

PAO-M10-17-NI-010
FDA

FDA Attracts Big Tech Companies in Effort to Develop Digital Health Apps

PAO-M10-17-NI-005
FDA Approval

FDA Approves Grifols’ Prolastin-C Liquid

PAO-M09-17-NI-032
Innovation

Potential Breakthrough HIV/AIDS Intervention Developed

PAO-M09-17-NI-035
CDMO CRO

New CDMO/CRO Collaboration Announced

PAO-M09-17-NI-026
In Conversation

Mergers & Acquisitions: Combining Market Segments

PAP-Q3-17-IC-001
Drug Development

Cladribine Demonstrates Disease Control with Shorter-Course Treatment

PAO-M09-17-NI-015
Biosimilar

Another Biosimilar Gets FDA Nod

PAO-M09-17-NI-011
Innovation

Post-Approval Studies Confirm Therapeutic Value of Oral Anticoagulants

PAO-M09-17-NI-005
Drug Development

Lilly Tackling Autoimmune Diseases Using Antigen Technology from Topas Therapeutics

PAO-M09-17-NI-004
Biologics

New FDA Draft Guidance on Manufacturing Changes for Biologics Issued

PAO-M08-17-NI-034
IND

FDA Accepts VBI Vaccines’ IND to Treat Glioblastoma Multiforme

PAO-M08-17-NI-028
Oncology

Quadruple Myeloma Combination Treatment Study Begins

PAO-M08-17-NI-027
Neuroprosthetics

Study Projects an $18 Billion Neuroprosthetics Market by 2028

PAO-M08-17-NI-022
Acquistion

Brains On-Line Acquired by Charles River Laboratories for $21 million

PAO-M08-17-NI-017
Clinical Trials

Novel Pneumonia-Fighter Enters Pivotal Trial

PAO-M08-17-NI-011
Facility

WuXi Passes Pre-License Inspection for mAb-Based HIV Treatment Production

PAO-M08-17-NI-008
R&D

Michael J. Fox Foundation and CASIS Partner to Grow Parkinson’s Protein in Space

PAO-M08-17-NI-005
Innovation

Potential Alzheimer’s Drug Targets Identified

PAO-M07-17-NI-034
Healthcare

Jefferson Health, GE Healthcare Collaborate on Healthcare Delivery

PAO-M07-17-NI-031
Biosimilar

FDA Recommends Approval of Trastuzumab Biosimilar

PAO-M07-17-NI-025
R&D

Science Exchange Raises $28 million in Series C Funding

PAO-M07-17-NI-021
PD-1 Inhibitor

Celgene Corp. and BeiGene Enter Strategic Collaboration

PAO-M07-17-NI-015
FDA Approval

Amgen’s Vectibix Approved for RAS Metastatic Colorectal Cancer

PAO-M07-17-NI-010
Biosimilars

FDA Approves Celltrion/Teva BLA for Rituximab Biosimilar

PAO-M07-17-NI-006
Expansion

Pfizer Breaks New Ground in Missouri

PAO-M07-17-NI-003
Drug Development

New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab

PAO-M06-17-NI-020
FDA

FDA’s Gottlieb Weighs in on the Drug Quality and Security Act (DQSA)

PAO-M06-17-NI-018
Acquisition

Upsher-Smith Laboratories’ Generics Business Now Part of Sawai Pharmaceutical

PAO-M06-17-NI-016
Biologics

Sanofi Will Increase Investments in Biologics

PAO-M06-17-NI-012
Expansion

Takeda Begins Expansion of its Manufacturing Footprint in Ireland

PAO-M06-17-NI-009
FDA

Roche CMV Viral Load Test Platform Gets FDA Nod

PAO-M06-17-NI-005
Strategic Partnership

Mayo Clinic and Baxter Launch Patient Centric Kidney Disease Initiative

PAO-M06-17-NI-004
Innovation

The Link Between Cancer and the Flu Virus

PAO-M05-17-NI-037
Data Management

Keeping Track of Antibiotic Resistance Just Got Easier

PAO-M05-17-NI-031
Pain Management

The Cost of Pain

PAO-M05-17-NI-027
Acquisition

Astellas Completes Acquisition of Ogeda

PAO-M05-17-NI-026
Clinical Trials

New Licensing Agreement Could Lead to Improved Brain Cancer Treatment

PAO-M05-17-NI-017
Pharma

First New ALS Treatment in Decades Approved by FDA

PAO-M05-17-NI-015
Innovation

There’s New Hope for Keeping Aging Muscles Healthy

PAO-M05-17-NI-012
Regulatory

EPA Pollution Expert Dr. Jeffery Morris Added to InformEx 2017 Speakers

PAO-M05-17-NI-007
Innovation

Recipharm Delivers First Serialized Drug Products in Saudi Arabia

PAO-M05-17-NI-003
Biosimilars

Biosimilar Era Begins to Blossom

PAO-M04-17-NI-027
CDMO

Upcoming: Women in Leadership Forum

PAO-M04-17-NI-023
Excipients

Co-Processed Excipients Help Formulate Better OSDs

PMP-A04-17-NI-001
Logistics

Bain Capital, Cinven and STADA Make a Deal

PAO-M04-17-NI-016
Equipment

Bioprocessing Technologies Dominate INTERPHEX Exhibitor Awards

PAO-M04-17-NI-008
CDMO

Vetter’s Roth Appointed to Fraunhofer Advisory Board

PAO-M04-17-NI-004
Biomanufacturing

Eli Lilly to Spend $850 Million on U.S. Manufacturing

PAO-M03-17-NI-018
Regulatory

FDA Issues Warning to Two More Companies

PAO-M03-17-NI-013
Regulatory

FDA, EMA Complete Mutual Recognition Journey

PAO-M03-17-NI-006
CDMO

Continuous Manufacturing: To Be Continued…

PAP-Q1-17-VP-001
CDMO

Lifecycle Management Strategies Can Uncover Hidden Value

PMP-M03-17-NI-001
CRO

Spray Drying Enhances Solubility and Bioavailability

PMO-M01-17-NI-001
CRO

2016 CRO Industry Leaders

PAP-Q1-16-IL-002
CDMO

2016 CDMO Industry Leaders

PAP-Q02-16-IL-001
Equipment

The Importance of Flexibility: Competitive Solutions in an Era of Innovation

PAP-Q04-16-IC-001
Packaging

Pharmaceutical Packaging: Differentiation Equates to Brand Loyalty

PAP-Q04-16-VP-001
Outsourcing

Shaping the Conversation – Bringing Voice & Value

PAP-Q04-16-ED-001
API

Targeted, Highly Potent Therapies: Big Growth Driver for the CDMO Market is Here...

SCP-M09-16-NI-001
Continuous Manufacturing

Innovating Equipment: Inline Buffer Dilution Technology

PAP-Q03-16-IC-001
Equipment

Novel Equipment Solutions: Leading to Manufacturing Efficiency and Productivity

PAP-Q03-16-IR-001
Excipients

What Are the Latest Guidelines for Excipients?

POP-M07-16-NI-001
CDMO

Sponsor Company Size Influences Contract Service Provision

POP-M05-16-NI-001

Research Database Recommendations

PAP-Q02-16-NI-001

Bioavailability: What Are Your Thoughts On Enhancing Bioavailability With Novel Technologies?

PAP-Q02-16-RT-001

From Qualified to Ideal: The Importance of Partnership

PAP-Q02-16-VP-001

Biosimilars: Are We on the Edge of a New Era of Biologics?

PAP-Q02-16-RT-002
Excipients

Optimising Excipients to Improve Bioavailability

MCP-M03-16-NI-001
Outsourcing

Look for More Outsourcing of Research Activities in 2016

APR-M01-16-NI-002

Customer Experience: Key to Growth in the Outsourced Services Industry

PAP-Q1-16-IC-001